Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of the Opal Patient Portal Application for Daily Follow-up of People at Home With COVID-19: The Opal-COVID Feasibility Study

NCT04978233 is registered in ClinicalTrials.gov with Dr. Bertrand Lebouche as lead sponsor.

NCT NCT04978233
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04978233 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of the Opal Patient Portal Application for Daily Follow-up of People at Home With COVID-19: The Opal-COVID Feasibility Study
Lead sponsor
Dr. Bertrand Lebouche
Phase
Observational
Overall status
Completed
Start date
December 8, 2020
Completion date
March 31, 2021
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19